• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of aminophylline on amygdaloid-kindled postictal inhibition.

作者信息

Albertson T E

出版信息

Pharmacol Biochem Behav. 1986 Jun;24(6):1599-603. doi: 10.1016/0091-3057(86)90492-2.

DOI:10.1016/0091-3057(86)90492-2
PMID:3737628
Abstract

Previous studies have shown that methylxanthines such as aminophylline increase the clinical severity and length of electrically elicited limbic afterdischarges in naive and kindled rats without lowering seizure threshold. When fully amygdaloid-kindled rats are electrically stimulated at intertrial stimulation intervals of less than 60 minutes, significant residual inhibition can be demonstrated. The present study examines the effect of three doses of aminophylline (25, 50 and 100 mg/kg) on repeated daily stimulations of fully amygdaloid-kindled rats. After 100 mg/kg aminophylline, the first elicited amygdaloid-kindled seizure afterdischarge was doubled in length compared to saline controls. The second elicited seizure 15 minutes later resulted in status epilepticus and hindlimb extension in the majority of the aminophylline-treated animals with death occurring in 28%. When 25 or 50 mg/kg of aminophylline was given daily for five days before the first of five daily stimulation trials, each separated by 15 minutes, no significant reduction in postictal inhibition was demonstrated compared to saline controls. The 50 mg/kg aminophylline dose consistently and significantly lengthened only the first afterdischarge of each day without affecting the postictal inhibition seen with repeated stimulations. The neural substrate that governs immediate postictal inhibition of amygdaloid-kindled seizures appears to be resistant to modification by aminophylline at low doses. At high doses of aminophylline (100 mg/kg), sustained epileptical activity occurred. The sustained seizure activity seen at the high dose of aminophylline may be secondary to blockade of the processes which normally terminate seizure activity, or it may represent actual inhibition of the immediate postictal inhibitory processes.

摘要

相似文献

1
Effect of aminophylline on amygdaloid-kindled postictal inhibition.
Pharmacol Biochem Behav. 1986 Jun;24(6):1599-603. doi: 10.1016/0091-3057(86)90492-2.
2
Aminophylline and kindled seizures.氨茶碱与点燃式癫痫发作
Exp Neurol. 1983 Sep;81(3):703-13. doi: 10.1016/0014-4886(83)90337-0.
3
Modification of amygdala-kindled postictal inhibition by pentylenetetrazol and diazepam.戊四氮和地西泮对杏仁核点燃后抑制的影响
Exp Neurol. 1987 Sep;97(3):626-34. doi: 10.1016/0014-4886(87)90119-1.
4
Amygdala-kindled postictal inhibition: effect of intertrial intervals on repeated days.杏仁核点燃后的发作后抑制:试验间隔对重复天数的影响
Exp Neurol. 1986 Apr;92(1):197-206. doi: 10.1016/0014-4886(86)90134-2.
5
Interactions of aminophylline and three benzodiazepine compounds with amygdala-kindled seizures in rats.
Exp Neurol. 1987 Sep;97(3):725-9. doi: 10.1016/0014-4886(87)90128-2.
6
The effect of a glycine derivative (CP 1552-S) on kindled seizures in rats.
Neuropharmacology. 1984 Aug;23(8):967-70. doi: 10.1016/0028-3908(84)90012-1.
7
Anticonvulsant role of adenosine.腺苷的抗惊厥作用。
Pol J Pharmacol Pharm. 1987 Sep-Oct;39(5):537-43.
8
Caffeine modification of kindled amygdaloid seizures.咖啡因对点燃杏仁核癫痫发作的影响
Pharmacol Biochem Behav. 1983 Aug;19(2):339-43. doi: 10.1016/0091-3057(83)90062-x.
9
The anticonvulsant action of AHR-11748 on kindled amygdaloid seizures in rats.AHR-11748对大鼠杏仁核点燃癫痫发作的抗惊厥作用。
Epilepsy Res. 1987 Mar;1(2):126-33. doi: 10.1016/0920-1211(87)90018-0.
10
Modification of amygdaloid kindling by diazepam in juvenile rats.地西泮对幼年大鼠杏仁核点燃的影响
Brain Res Dev Brain Res. 1990 Feb 1;51(2):249-52. doi: 10.1016/0165-3806(90)90282-4.